Clinical Trial Update: Low-dose Aspirin Therapy for Esophageal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of low-dose aspirin for esophageal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Low-dose aspirin (acetylsalicylic acid)

Snippet

Sponsor: Zhejiang University | Conditions: Esophageal Cancer | Phase 3 | Status: WITHDRAWN